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Abstract
Aims Left ventricular diastolic pressure estimation is essential for characterization of heart failure (HF). Patients with normal 
resting left atrial (LA) pressures (LAP), but steep LAP elevation on exertion, pose a particular diagnostic challenge. Cur-
rent recommendations on echocardiographic LAP estimation have limited accuracy. Our aim was to investigate whether LA 
mechanical alterations assessed by LA strain (LA-GS) can contribute to non-invasive LAP diagnostics.
Methods and results Simultaneous echocardiographic and right heart catheterization (RHC) data at rest and during exercise 
was analyzed in 164 prospectively enrolled patients, referred for RHC due to HF symptoms. 56% had preserved ejection 
fraction (pEF). At rest, 97 patients displayed elevated mean pulmonary arterial wedge pressure  (PAWPM); further 32 patients 
had normal resting, but elevated  PAWPM during exercise. LA-GS demonstrated a stronger relationship with resting  PAWPM 
(r = − 0.61, p < 0.001) than any of the indices (E/e′, LAVi,  TRVmax) incorporated in the currently recommended diagnostic 
algorithm. The diagnostic ability of LA-GS for detecting elevated resting  PAWPM (AUC: 0.80, p < 0.001) outperformed that 
of the recommended algorithm (AUC: 0.69). Importantly, resting LA-GS performed even better in identifying patients with 
pathological  PAWPM either at rest or during stress (AUC: 0.90, p < 0.001), whereas the diagnostic potential of the current 
algorithm was modest and limited to pEF patients (AUC = 0.72). Finally, among the non-invasive indices, LA-GS entailed 
the strongest prognostic value for death or heart transplantation (OR: 2.7; p < 0.05).
Conclusion LA-GS comprises a robust method for  PAWPM assessment at rest. More importantly, it reliably discerns patho-
logical  PAWPM rise on exertion despite normal resting pressures.
Keywords Left atrial strain · Non-invasive · Invasive · Exercise · Diastolic pressures
Introduction
Diagnostic, prognostic and therapeutic reasons confer to 
the non-invasive estimation of left ventricular (LV) filling 
pressures fundamental importance when evaluating patients 
presenting with unexplained dyspnea as well as those with 
documented heart failure (HF). Despite extensive research 
and the availability of numerous metrics, the assessment of 
resting LV diastolic pressures is challenging. Even more 
puzzling is the non-invasive diagnostics of patients whose 
resting left atrial (LA) pressure (LAP) is within normal 
range, but increases abnormally steeply on exertion [1, 2].
Current guidelines recommend the use of a multi-par-
ametric algorithm (ASE/EACVI algorithm) for LAP esti-
mation [3]. However, despite significant improvements in 
feasibility [4], as compared to previous recommendations, 
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validating studies have demonstrated that the proposed 
approach entails only moderate diagnostic value for rest-
ing LAP [5, 6], which is further restricted for identifying 
patients with excessive LAP elevation on exertion despite 
normal resting pressures [2]. Finally, although ventricular 
pacing is frequent in HF patients, there is ambiguity regard-
ing the proper use of the currently recommended method in 
this cohort.
LA function has gained recognition as an important focus 
area in the assessment of LV diastolic function [7–9]. LA 
reservoir function is influenced both by the LV performance 
and by the intrinsic LA compliance and plays an impor-
tant role in disease progression in various clinical states 
including HF [10–13]. Quantitative LA deformation analy-
sis using speckle tracking has evolved as a highly feasible 
and reproducible method for evaluating LA function. It has 
been proven that LA global strain (LA-GS) is associated 
with mechanical changes and fibrosis even prior to LA geo-
metrical remodeling [8, 14, 15], potentially enabling earlier 
diagnosis of elevated LAP. Previous studies have shown an 
inverse relationship between LA-GS and the diastolic pres-
sures [5, 16]. Accordingly, we hypothesized that LA-GS 
might contribute to improve the non-invasive assessments 
of elevated LAP, and set out to assess its diagnostic value in 
that setting. Furthermore, we opted to investigate the appli-
cability of LA-GS in patients on ventricular pacing.
Methods
Study population
All consecutive patients referred right heart catheterization 
(RHC) at the Karolinska University Hospital for the HF 
assessment between February 2014 and June 2017 (n = 220) 
were screened for enrollment. In all cases medical treatment 
had been titrated and hemodynamic stabilization achieved 
at the time of examination. No patient presented with acute 
coronary syndrome or had undergone cardiac surgery for a 
period of < 1 year prior enrollment. The study conformed 
to the Declaration of Helsinki, had ethics approval by local 
ethics committees and all participants provided written 
informed consent.
Echocardiography
All subjects underwent transthoracic echocardiography 
using an E9 system (GE Ultrasound, Horten, Norway) 
equipped with a 2.5 MHz matrix array transducer in keeping 
with current guidelines. 2D gray-scale images were acquired 
over 3 heart cycles and analyzed off-line (EchoPAC PC, ver-
sion 11.0.0.0 GE Ultrasound, Waukesha, Wisconsin) by a 
single sonographer blinded to clinical and RHC data. LV 
end-diastolic, end-systolic volume and ejection fraction (EF) 
were measured using the Simpsons biplane method [17]. For 
LA volumetric analysis, the ‘method of disk’ method was 
employed. Myocardial deformation was analyzed by 2-D 
speckle tracking. LV global longitudinal strain (LV-GLS) 
was calculated as the average value of 12 segments obtained 
from the apical 4- and 2-chamber views. LA global strain 
(LA-GS) was assessed using images obtained in apical 4- 
and 2-chamber views (frame rate: 60–80 Hz), with atten-
tion for optimal visualization of the LA. Acoustic tracking 
was performed by semi-automated analysis. The endocar-
dial border of the LA was traced manually so that the LA 
appendage and pulmonary veins were excluded, then an 
additional epicardial line was automatically generated by 
the software creating a region of interest (ROI), the shape of 
which was manually adjusted to precisely draw out the atrial 
contour and cover the full thickness of atrial myocardium 
(Fig. 1). Automatic processing was controlled by 1, visual 
confirmation of correct tracking of the endocardial border 
throughout the cardiac cycle and 2, by automated self-check 
function of the software. In case the tracking did not seem 
appropriate according to the reader or a segment was not 
approved by the software, repeated manual adjustment of 
the ROI was performed. If repeated processing did not result 
in an approved strain curve, the loop was excluded from the 
analysis (n = 4 cases). Following approval, the software auto-
matically divided the LA endocardium into six segments, 
and longitudinal strain curves for each segment were gener-
ated. Zero point was set at the onset of the QRS complex on 
the ECG. LA reservoir function was estimated by peak LA 
longitudinal strain during ventricular systole. LA-GS was 
calculated by averaging strain measurements from all the 
segments. In patients in sinus rhythm, measurements from 3, 
in patients in AF (n = 42) measurements from 5 consecutive 
beats were averaged. Loops were carefully recorded so that 
PVCs/PACs were avoided. Reproducibility was tested in 40 
randomly selected patients. The early (E) and late (A) mitral 
flow velocities were recorded using a 5 mm pulsed wave 
(PW) sample volume. Tricuspid regurgitation peak velocity 
 (TRVmax) was recorded employing continuous wave Dop-
pler. Spectral tissue velocities were recorded in the septal 
and lateral mitral annulus using a 5 mm PW sample vol-
ume and the early myocardial relaxation velocity (e′) was 
recorded. The E/e′ ratio was calculated from the average 
of septal and lateral myocardial velocities. At the time of 
examination 42 patients were in AF.
Catheterization
Within 1 h following echocardiography, RHC was performed 
using a 6F Swan-Ganz catheter through the jugular or femo-
ral vein. Mean right atrial pressure, the systolic-, diastolic-, 
mean pulmonary artery pressure  (PAPM) and the mean 
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pulmonary artery wedge pressure  (PAWPM) were recorded 
under fluoroscopy after calibration with the zero-level set at 
the mid-thoracic line. Pressure tracings were stored (WITT 
Series III, Witt Biomedical Corp., Melbourne, FL) and ana-
lysed offline.  PAWPM measurements were averaged from a 
minimum of 5 heart cycles at spontaneous end-expiration.
Exercise protocol
Following the assessment of resting hemodynamics, patients 
with normal  PAWPM at rest (≤ 15 mmHg) performed supine 
cycle ergometry. Patients cycled at 60 rpm starting at a 20 W 
workload and increasing by 10 W increments in 1-min stages 
to maximum tolerated levels.  PAWPM was determined at 
peak exercise. Prior studies in normal controls have shown 
that peak  PAWPM during supine exercise are < 20–23 mmHg 
[18, 19]. In our study,  PAWPM ≥ 23 mmHg during peak 
exercise denoted abnormal LAP response.
Biomarkers
NT-proBNP was analyzed by proBNPII (Roche Diagnos-
tics, Bromma, Sweden). Estimated glomerular filtration rate 
(eGFR) was calculated according to the MDRD study equa-
tion: eGFR = 175 × [creatinine] − 1.154 ×  106−0.203 × 0.742 
[if female] mL/min/1.73; Creatinine in mg/dL, age in years.
Statistical analysis
The IBM SPSS statistics version 23.0 was used. QQ plots 
tested normality. Continuous variables are expressed as 
median and interquartile range. Categorical variables 
were expressed as absolute values and percentage. For 
Fig. 1  Left atrial strain curves obtained from four- and two-chamber 
views. The white dotted line indicates the mean strain value over the 
heart cycle in each view. LA reservoir function was estimated by peak 
LA longitudinal strain during ventricular systole. Global left atrial 
strain (LA-GS) was calculated by averaging the peak LA strain values 
from all 12 segments
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comparisons of different groups, the Mann–Whitney test was 
used. Correlations were tested by the Pearson’s 2-tailed test 
or Spearman test, as appropriate. All tests were performed 
at 95% confidence intervals. A p value of < 0.05 was con-
sidered statistically significant.
The association of invasive and non-invasive diastolic 
indices with the combined outcome of death or heart-trans-
plantation (HTX) was tested using a time to event analysis 
with univariate and multivariable Cox proportional hazards 
models, adjusting for demographic, clinical and echocardio-
graphic covariates (E/e′,  TRVmax, age, hypertension, diabe-
tes, LV-EF, ln[NT-proBNP] and eGFR) and a Kaplan–Meier 
non-parametric test and compared employing a log-rank test. 
The proportional hazards assumption was tested for all anal-
yses. Receiver-operating characteristic (ROC) curves were 
plotted for individual parameters regarding the discrimina-
tion of increased  PAWPM and to establish the optimal cut-off 
points.
NT-proBNP data were natural logarithmically trans-
formed. Analysis of intra-observer variability was performed 
for LA-GS by double measurements in 40 randomly selected 
patients. Inter-observer variability together with test–retest 
reliability was tested in 29 individuals, who have undergone 
two consecutive examinations each, within 20 min, per-
formed by two different examiners and then the two record-
ings analysed again by two different readers.
Results
Patient characteristics
Demographic data are provided in Table 1. In total 220 
patients referred for diagnostic right heart catheterization 
(RHC) with suspected HF or unexplained dyspnea were 
prospectively screened. Of the 220 patients catheterized, 11 
patients who previously underwent cardiac transplantation 
with atrial anastomosis technique were excluded. By the 
results of catheterization, 29 patients turned out to have an 
underlying disease other than primary left heart myocardial 
disease (isolated pre-capillary arterial pulmonary hyperten-
sion, n = 15; constrictive pericarditis, n = 14), and therefore, 
were excluded from further analysis. In addition, 3 patients 
with ARVD, 10 patients with significant valvular disease and 
3 patients with inadequate echocardiographic image quality 
were also excluded from further analysis (Figure S1).
In effect, recordings of 164 patients were analyzed 
(age 63 ± 15; 74 female). Median EF was 54% (Q1:25%, 
Q3:62%), 72 patients (44%) had EF < 50% (HFrEF). At the 
time of enrollment all patients were symptomatic. Ischemic 
cardiomyopathy was the cause of HF in 26 cases, idiopathic 
dilated cardiomyopathy in 53, restrictive cardiomyopathy 
of various origin in 23 (amyloidosis: 5, sarcoidosis: 1, 
hypertrophic: 5, other: 12), and viral myocarditis in 1 case, 
with the rest being of multifactorial origin.
At rest, 97 patients (59%) demonstrated elevated  PAWPM 
(> 15 mmHg). Additionally, 32 patients with normal rest-
ing  PAWPM displayed abnormal LAP (≥ 23 mmHg) during 
exercise [preserved EF (pEF), n = 17 (19%); HFrEF, n = 15 
Table 1  Demographic data stratified according to EF groups
Categorical variables are provided as absolute numbers followed by 
percentages in brackets; continuous variables or median values fol-
lowed by 1st and 3rd quartiles in brackets
EF ejection fraction, AF atrial fibrillation or flutter, PM pacemaker, 
CRT cardiac resynchonization therapy, NYHA New York Heart Asso-
ciation functional class, BMI body mass index, SBP systolic blood 
pressure, DBP diastolic blood pressure, HR heart rate, ARB angioten-
sin receptor blocker, ACE-I ACE-inhibitor, MRA mineralocorticoid 
receptor antagonist, NT-proBNP N-terminal pro-brain natriuretic pep-
tide, eGFR estimated glomerular filtration rate
General character-
istics
EF ≥ 50% EF < 50% p value
(n = 92) (n = 72)
Age years 73 (67; 79) 58 (47; 64) < 0.001
Female 57 (62%) 15 (21%) < 0.001
Medical history and symptoms 
AF 44 (48%) 33 (46%) 0.799
PM/CRT 8/0 (9%) 8/16 (33%)
Hypertension 63 (69%) 42 (58%) 0.30
Diabetes mellitus 17 (19%) 13 (18%) 0.84
Hypercholesterol-
aemia
22 (24%) 23 (32%) 0.197
Ischaemic heart 
disease
3 (3%) 19 (26%) < 0.001
NYHA I 12 (13%) 1 (1%)
NYHA II 18 (20%) 9 (13%)
NYHA III 59 (64%) 56 (78%)
NYHA IV 3 (3%) 6 (8%)
Clinical measurements 
BMI kg/m2 27 (23; 30) 27 (24; 31) 0.63
Obesity (BMI ≥ 30) 25 (27%) 19 (26%) 0.911
SBP (mm Hg) 130 (117; 142) 101 (93; 115) < 0.001
DBP (mm Hg) 67 (60; 71) 62 (55; 70) 0.04
HR (beats/min) 70 (60; 80) 68 (59; 77) 0.51
Treatment
ARB or ACE-I 50 (54) 64 (89) < 0.001
Loop diuretic 63 (69) 65 (90) 0.001
Beta blocker 61 (66) 68 (94) < 0.001
MRA 30 (33%) 53 (74%) < 0.001
Calcium channel 
blocker
26 (28) 5 (7) = 0.001
Laboratory findings 
NT-proBNP (ng/L) 1250 (365; 2300) 2580 (1265; 2693) < 0.001
eGFR (mL/
min/1.73 m2)
65 (46; 88) 81 (68; 102) < 0.001
Hemoglobin (mg/L) 123 (113; 140) 138 (125; 148) < 0.001
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(21%)]. In total 129 (79%) patients had elevated LAP either 
at rest or during exertion. In 8 cases, the exercise testing 
was not feasible due lower extremity pain (n = 3) or inability 
to follow instructions (n = 5). Echocardiographic and inva-
sive measurements for pEF and HFrEF are summarized in 
Table 2.
At the time of examination, 42 (26%) patients were in 
atrial fibrillation (AF) and 32 patients (19%) had continuous 
ventricular pacing (VP) (CRT in 16 cases).
Echocardiographic metrics and PAWP
In the whole cohort,  PAWPM showed a significant inverse 
correlation with LA-GS (r = − 0.54, p < 0.001) and weaker 
albeit significant relationship with  TRVmax, LAVi and 
E/e′ (r = 0.41, 0.29, 0.28, respectively; p < 0.001 for all). 
The ASE/EACVI algorithm for diastolic assessment does 
not apply to patients in AF or those with ventricular pac-
ing. Nonetheless, as LA-GS has not yet been thoroughly 
investigated in this setting, we decided to study its validity 
in these specific subgroups. Conceivably, AF might impor-
tantly influence LA-GS measurements. Accordingly, sepa-
rate analysis of the AF group confirmed that neither LA-GS 
(r = − 0.26, p = 0.092), nor LAVi (r = − 0.116, p = 0.46) 
or E/e′ (r = 0.21, p = 0.19) were associated with  PAWPM. 
In contrast, in the VP group,  PAWPM significantly corre-
lated with LA-GS (r = − 0.54, p = 0.002) and E/e′ (r = 0.41 
p = 0.021), but lacked association with either LAVi or 
 TRVmax (r = − 0.14 and 0.2, p > 0.05 in both cases).
Confining the analysis to patients in sinus rhythm (SR) 
(i.e., where the currently recommended algorithm is appli-
cable), the correlations between  PAWPM and LA-GS, 
LAVi and  TRVmax were stronger (r = − 0.66, 0.51 and 0.46 
respectively, p < 0.001 for all). However, the E/e′ remained 
only weakly associated with  PAWPM (r = 0.25, p < 0.018). 
Accordingly, we decided to proceed with all further analysis 
in the cohort in regular rhythm (RR), i.e., both those in SR 
and VP and to exclude patients with AF.
Table 2  Cardiac geometric and 
functional measures in the two 
groups stratified according to 
EF
Data are provided as median values followed by 1st and 3rd quartiles in brackets. Patient numbers for each 
measurement are provided in brackets
BMI body mass index, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure, LV left 
ventricle, EDVi end-diastolic volume index, ESVi end-systolic volume index, LVMi LV mass index, EF 
ejection fraction, LV-GLS LV global longitudinal strain, E/A ratio between the early diastolic inflow veloc-
ity (E) to the inflow velocity due to atrial contraction (A), e′ mean, mean value of early myocardial velocity 
in LV basal septal and lateral wall, E/e′ ratio between the E and the e′, LA left atrium, LA ESVi left atrial 
end-systolic volume, LA-GS left atrial global longitudinal strain, TAPSE tricuspid annular plane systolic 
excursion, RVSP right ventricular systolic pressure as assessed by echocardiography, PAWPM pulmonary 
arterial wedge pressure, PAPM pulmonary arterial mean pressure, NS non-significant (p ≥ 0.05)
EF ≥ 50% (n = 92) EF < 50% (n = 72) p value
LV dimensions 
LV EDVi (mL/m2) 47 (39; 61) (88) 99 (78; 132) (62) < 0.001
LV ESVi (mL/m2) 16 (12; 24) (88) 75 (46;101) (62) < 0.001
LVMi (g/m2) 88 (69; 111) (88) 139 (103; 164) (71) < 0.001
LV systolic function
LV-EF (%) 60 (57; 65) (92) 25 (20; 40) (72) < 0.001
LV-GLS (%) 18 (14; 20) (91) 6.8 (4.9; 10) (71) < 0.001
LV diastolic function
E/A ratio 1.3 (0.9; 2.1) (60) 2.9 (1.7; 3.9) (57) < 0.001
e′ septal 6.9 (5.0; 8.0) (92) 4.5 (3.3; 60) (72) < 0.001
e′ lateral 8.1 (6.6; 10.9) (92) 7.5 (6.0; 10.0) (72) NS
E/e′ 12.5 (9.5; 18.4) (91) 15.3 (11.5; 23.7) (72) 0.015
LA function
LA ESVi (mL/m2) 42 (34; 53) (92) 60 (44; 69) (72) < 0.001
LA-GS (%) 12.0 (7.0; 17.9) (90) 7.9 (5.0; 10.1) (70) < 0.001
RV parameters
TAPSE (mm) 17 (13; 22) (92) 14 (11; 17) (71) 0.002
RVSP (mmHg) 44 (37; 58) (90) 46 (36; 57) (66) NS
Hemodynamic
PAWPM (mmHg) 16 (13; 22) (91) 19 (14; 25) (72) 0.023
PAPM (mmHg) 26 (21; 37) (92) 29 (22; 37) (72) NS
Cardiac Index (mL/m2) 2.5 (2.0; 2.9) (92) 2.0 (1.6; 2.3) (72) < 0.001
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In a multivariable analysis including LA-GS, LAVi, 
 TRVmax, E/e′ and LV-GLS, the LA-GS was identified as the 
strongest predictor of  PAWPM with a partial correlation of 
r = − 0.42 (p < 0.001) in RR patients. The correlation for 
 TRVmax was r = 0.33 (p < 0.001), while the other variables 
were not associated with  PAWPM (p > 0.05). Similarly, in the 
SR cohort, LA-GS and  TRVmax were identified as the only 
predictors of  PAWPM (partial correlations r = − 0.40 and 
r = 0.33 respectively, p < 0.001), whereas the other variables 
were not associated with  PAWPM (p > 0.05). No correlation 
between LV-GLS and  PAWPM was found in either EF group 
(p > 0.05).
As shown in Table 3a, when dividing our RR cohort 
based on the EF, compared to the other non-invasive metrics, 
LA-GS displayed the strongest correlation with  PAWPM in 
both EF groups (r = − 0.61 and − 0.46 in pEF and HFrEF, 
respectively, p < 0.001 for both) (Fig. 2). Notably, the cor-
relation between LA-GS and  PAWPM was strongest in the 
preserved EF group; further stratification of our cohort into 
moderately and severely reduced EF confirmed a progres-
sively weaker LA-GS–PAWPM correlation along with lower  
EF ranges (EF 30–49%: r = − 0.54 p = 0.014; EF < 30%, r 
= − 0.36 p = 0.03). Echocardiographic and haemodynamic 
characteristics of these subgroups are provided in Table S1. 
LAVi and  TRVmax were also significantly related to  PAWPM 
(p < 0.05), whereas the correlation of E/e′ with  PAWPM was 
confined to pEF patients (r = 0.32, p = 0.002).
Correlation between non‑invasive markers 
and NT‑proBNP
In patients with RR, NT-proBNP was strongly associ-
ated with LA-GS (r = − 0.64, p < 0.001) with significant 
but weaker correlation with  PAWPM, LAVi (r = 0.40 and 
0.52, respectively; p < 0.001 for both) and E/e′ (r = 0.25; 
p = 0.012) but not with  TRVmax (p > 0.05). In a multivariable 
analysis including LA-GS, LAVi,  TRVmax, E/e′ and LV-GLS, 
the LA-GS remained the sole predictor of NT-proBNP with 
a partial correlation of r = − 0.43 (p < 0.001).
Echocardiographic metrics for elevated LAP at rest 
and during exercise
As illustrated in Table 3, LAVi and the ASE/EACVI algo-
rithm provided fairly good ability to rule out elevated rest-
ing  PAWPM. However, their specificity was limited and for 
the ASE/EACVI algorithm restricted to pEF patients. In 
contrast, LA-GS yielded a more robust discrimination for 
resting  PAWPM, particularly in the pEF group (LA-GS cut-
off: 15%, specificity and sensitivity 83% and 89%, respec-
tively; p < 0.0001). HFrEF patients displayed generally lower 
LA-GS values, therefore, at an optimal cut-off value of 8% in 
this cohort, a specificity of 61% and sensitivity of 68% was 
achieved (p = 0.002) (Fig. 3A).
Even more diagnostically challenging are those patients 
displaying resting LAP within the normal range, but an 
abnormal pressure elevation on exertion. Importantly, we 
found that taking into account all patients with elevated LAP 
either at rest or during exercise, the predictive value LA-GS 
improved further. In patients with pEF, resting LA-GS (cut-
off: 21%) displayed a specificity and sensitivity of 88% and 
92%, while in HFrEF (cut-off 15%) the corresponding values 
for identifying pathological LAP at rest or during stress were 
67% and 92%, respectively (Fig. 3c). Noticeably, invasive 
 PAWPM measurements at rest had lower sensitivity com-
pared to LA-GS in this diagnostic setting. Finally, the ASE/
EACVI algorithm demonstrated limited specificity in pEF 
patients (specificity: 56%, sensitivity: 88%, AUC = 0.72; 
p = 0.011) and in fact no significant diagnostic information 
in the HFrEF group (Fig. 3b).
Recently, a multivariable approach based on echocar-
diographic (Doppler derived pulmonary artery systolic 
pressure, E/e′) and clinical (age, BMI, hypertension, atrial 
fibrillation) parameters for HFpEF diagnosis as assessed by 
invasive rest and exercise testing [20]. A weighted score 
based on the above 6 parameters  (H2FPEF) provided robust 
discernment of HFpEF (AUC 0.84). In our cohort, the mean 
 H2FPEF was 5 (3% of the patients had score 0; 5% score 
1; 3% score 2; 15% score 3; 16% score 4; 8% score 5; 14% 
score 6; 23% score 7; 3% score 8 and 9% had score 9). ROC 
analysis of the predictive ability of the score in the subgroup 
of patients with EF > 50% was 0.81 (0.71–0.91); p < 0.001. 
 H2FPEF score and the LA-GS demonstrated a significant 
inverse relationship (r = − 0.51, p < 0.001). The correspond-
ing association between the  H2FPEF score and the PAWP at 
rest was r = 0.44, p < 0.001, whereas there was no significant 
association with E/e′ (r = 0.12; p > 0.05).
Indices of diastolic function and outcome
The prognostic information provided by non-invasive and 
invasive metrics of LAP was subsequently evaluated. Using 
Kaplan–Meier analysis the predictive value of LA-GS (cut-
off: < 12%),  PAWPM (cut-off: > 15 mmHg) and E/e′ (cut-off: 
> 14) was investigated (Fig. 4). Over a median follow-up 
of 561 days (IQR: 270–839) 32 primary outcome events 
occurred [20 deaths, 12 HTX]. No patients were lost to fol-
low-up.  PAWPM > 15 mmHg was related with higher risk 
for death or HTX [hazard ratio (HR) 2.3; confidence interval 
(CI) 1.1–4.9, p = 0.022]. Furthermore, LA-GS < 12% was 
associated with an increased risk for the primary compos-
ite endpoint in unadjusted analysis [HR: 2.4, CI 1.1–5.2, 
p = 0.029] and was the sole independent predictor of out-
come when adjusted for E/e′ and  TRVmax, using the cut-off 
values recommended in the ASE/EACVI algorithm [HR: 
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2.8; CI 1.1–6.1, p = 0.017]. However, when adjusted for age, 
eGFR, hypertension, diabetes mellitus, LV EF and ln[NT-
proBNP], neither the LA-GS nor the  PAWPM retained their 
predictive potential, NT-proBNP remaining the sole signifi-
cant prognostic index (HR 1.53; p = 0.022) (Table S2).
Feasibility and reproducibility
Measurements of LAVi and E/e′ could be performed in all 
cases whereas the feasibility of LA-GS and  TRVmax were 
98% and 95%, respectively. In the present study the ASE/
EACVI algorithm provided a definite diagnosis in 99% of 
the cases, with only 1 case remaining indeterminate.
Double measurements for LA-GS in 40 randomly selected 
patients demonstrated a coefficient of variation of 10% with 
intra-class correlation coefficient 0.91 (95% CI 0.73–0.96).
Test retest analysis for the LA-GS yielded high reliability 
with a slightly higher coefficient of variation of 12.8%.
Discussion
In this prospective study we demonstrate that in patients 
with known or suspected HF, LA-GS provides a feasible and 
robust diagnostic tool for the identification of elevated LAP 
either at rest or on exertion, with this single measurement 
entailing higher diagnostic accuracy as compared to the cur-
rently recommended diagnostic algorithm. Furthermore, we 
show that among the tested non-invasive indices of filling 
pressures, LA-GS provides the best prognostic value in HF 
patients.
Recommended algorithm for the assessment 
of diastolic dysfunction
Given the limited individual accuracy of the established 
non-invasive metrics, the evaluation of LV filling pressures 
requires a number of parameters to be taken into account 
[21], rendering diastolic assessment a laborious task. In 
2016 the American Association of Echocardiography (ASE) 
together with the European Association of Cardiovascular 
Imaging (EACVI) published a new joint guideline proposing 
a novel algorithm, based on expert consensus [3], that com-
prises a simplified thus potentially more feasible approach 
for echocardiographic LAP estimation. A number of studies 
have since tested the diagnostic validity of this new algo-
rithm and concluded that it provides an improved yet still 
moderate sensitivity for elevated LAP [4–6, 21] along with 
fewer indeterminate cases compared to the previous recom-
mendations [4]. Our findings essentially corroborate these 
observations as we show that despite good feasibility, the 
diagnostic potential of the ASE/EACVI algorithm remains 
modest. More specifically, as compared to previous findings Da
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Fig. 2  Correlation of invasively 
measured  PAWPM values with 
left atrial global strain (LA-GS) 
(a) and E/e′ (b) in patients with 
regular rhythm with preserved 
(HFpEF) or reduced (HFrEF) 
ejection fraction
A B
 
 
 
A B C
Fig. 3  Diagnostic accuracy of LA-GS. ROC curve of LA-GS (blue) 
and the ASE/EACVI algorithm (green) for identifying elevated 
 PAWPM at rest (a) and at rest and/or during stress (b), independent of 
the EF. Beeswarm plot showing subjects with normal (blue) or patho-
logical (red)  PAWPM values at rest and/or during exercise, dichoto-
mized according to the EF (c). Optimal LA-GS cut-off values for pre-
served and reduced EF are 21% and 17%, respectively. LA-GS, left 
atrial global strain; ROC, receiver operating characteristics;  PAWPM, 
mean pulmonary arterial wedge pressure; EF, ejection fraction
A B C
Fig. 4  Prognostic value of LA-GS. Kaplan–Meier analysis of the pre-
dictive value of E/e′ (a), LA-GS (b) and invasively measured  PAWPM 
(c) on the composite outcome of death and/or HTX. LA-GS, left 
atrial global strain;  PAWPM, mean pulmonary arterial wedge pres-
sure; HTX, heart transplantation
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[2, 6] we show that the ASE/EACVI algorithm provided 
better ability for ruling out elevated LAP, compromised, 
however, by a poorer specificity, probably due to the higher 
prevalence of severe HF in our cohort.
LA‑strain for the assessment of resting LAP
Normally, the distensible LA accommodates the inflowing 
volume from the pulmonary veins with only a slight rise in 
the LAP. However, in HF structural and pro-inflammatory 
alterations often result in increased LA-wall stiffness, shift-
ing the LA pressure–volume curve upwards with accentu-
ated pressure elevation for the same volume entering the 
LA [22]. It appears, therefore, pathophysiologically sound 
to postulate that characterization of LA-wall mechanics 
might contribute to the diagnostics of diastolic function. 
Indeed, LA wall deformation as quantified by LA-GS has 
been shown to correlate well with LV filling pressures in 
systolic HF [5, 7, 14, 23]. Moreover, Hummel et al. demon-
strated that in HFpEF, as compared to established non-inva-
sive metrics, LA-GS exhibited a stronger relationship with 
 PAWPM [5]. In line with these observations we show that 
in both HFpEF and HFrEF patients, the predictive potential 
of LA-GS for elevated resting LAP was superior not only 
to individual established non-invasive markers, but to the 
ASE/EACVI algorithm as well. Particularly in pEF patients, 
the fairly high specificity of LA-GS was accompanied by a 
comparable ability for ruling out elevated resting LAP.
Diagnosis of patients with pathologically elevated 
resting or exercise‑induced LAP
Notwithstanding the evident challenge in regard to non-
invasive estimation of resting LAP, the diagnosis of patients 
presenting with exertional dyspnea comprises an even more 
perplexing undertaking. This becomes apparent in light 
of the findings of a recent study in which roughly 40% of 
HFpEF patients exhibited normal resting LAP, but displayed 
abnormal pressure elevation during exercise [5]. In our 
investigation, 20% of the invasively diagnosed HFpEF and 
HFrEF patients had normal resting, but elevated exercise 
LAP. Overall, the sensitivity of resting invasive hemody-
namics for identifying abnormal diastolic response during 
exertion was higher yet still moderate (70%) as compared 
to the aforementioned study [2], a discrepancy that might 
be ascribed to the higher prevalence of more severe HF 
in our cohort as indicated by the higher NT-proBNP and 
LAVi values. Although the ASE/EACVI algorithm was not 
specifically developed for this purpose, given this being the 
currently recommended method for the diagnosis of dias-
tolic dysfunction it is plausible to assume that patients with 
exercise induced pressure elevation and symptoms might 
score abnormal by this method. Obokata and colleagues 
were the first to validate the ASE/EACVI algorithm against 
the gold standard invasive exercise testing, demonstrating 
a fairly good specificity (80%) limited, however, by poor 
sensitivity (34%) in HFpEF [2]. Employing similar method-
ology our results show better sensitivity values and poorer 
specificity most possibly due to the more advanced HF in 
our study. Importantly, the ASE/EACVI approach applies to 
both patients with HFpEF and HFrEF [3]. However, accord-
ing to the current results, in HFrEF the multi-parametric 
approach at rest was not predictive for abnormal LAP eleva-
tion during exercise.
In contrast, LA-GS had even further increased discrimi-
natory capacity for pathological LAP when both resting- or 
exercise-induced values were taken into account. In fact, 
particularly in patients with pEF, resting LA-GS provided 
superior sensitivity than resting  PAWPM implying that 
LA-GS might be more sensitive in ruling out elevated 
 PAWPM during physical exertion than invasive examination 
in resting condition. LA-GS has been shown to inversely 
associate with the degree of LA-wall fibrosis as assessed 
by delayed-enhancement magnetic resonance imaging [24]. 
Furthermore, in patients undergoing mitral valve surgery, 
LA-GS comprised the strongest independent predictor of 
histologically quantified LA-wall fibrosis [14]. Conceivably, 
LA-GS might reflect the state of LA compliance, thus allow-
ing identification of elevated LAP at rest but even more pre-
dicting abnormal LAP response at states of increased flow 
conditions such as during exercise.
The physiologic concept of LA-LV volume reciprocity 
describes the inherent association between the LV and LA 
function whereby the LV systolic deformation impacts on 
LA mechanics [7, 22]. Indeed, the current results substanti-
ate this notion showing statistically significant association 
between LV-GLS and LA-GS (pEF: r = 0.36, p = 0.005; 
HFrEF: r = 0.38, p < 0.003). Nevertheless, as opposed to 
LA-GS, no correlation between LV-GLS and  PAWPM was 
found in either HF group (p > 0.05). More importantly, mul-
tivariate analysis demonstrated that LA-GS entailed an inde-
pendent predictive value for LAP, whereas LV-GLS lacked 
diagnostic potential in that setting. This is not surprising as 
LA-GS quantifies mechanical events at the LA level asso-
ciated with  PAWPM, as opposed to LV-GLS, which might 
better reflect LVEDP. Additionally, previous experimental 
studies have demonstrated differential cellular responses 
with more pronounced pro-fibrotic changes detected in the 
LA as compared to the LV wall [25, 26] which advocates 
for LA-GS entailing a diagnostic value that is independent 
of the LV-GLS [15].
As the current results reveal, the specificity of LA-GS for 
resting and/or exercise LAP elevation was higher in patients 
with pEF which might be ascribed to the disparate degree of 
LA remodeling with smaller LAVi in pEF (pEF: 42 ± 15 vs. 
HFrEF: 55 ± 17 mL/m2, p < 0.001). Indeed, the association 
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between LA-GS and  PAWPM was lower in patients with 
severely dilated LA (LAVi > 48 mL/m2) compared to those 
with mild to moderate LA enlargement (r = 0.69 vs. 0.30, 
p < 0.001). Although LA-GS is angle independent, extensive 
geometrical changes in LA might impact on the myocardial 
tracking. Additionally, the attenuation of wall stress second-
ary to LA dilatation might affect the reliability of LA-GS in 
predicting LAP [27].
Outcome
Filling pressures not solely impact on symptoms, but on 
prognosis as well as previously shown [1]. Employing the 
currently recommended  PAWPM value (> 15 mmHg) dem-
onstrated an increased event rate (death or HTX) in the 
elevated LAP group. However, when the non-invasive met-
rics of LAP were tested at the suggested discriminating val-
ues, only LA-GS comprised a prognostic value. Following 
adjustment for demographic and clinical parameters, neither 
the  PAWPM nor LA-GS remained diagnostic. The current 
findings might reflect inadequate power, but advocate as well 
for the complexity of the HF as a clinical entity.
Clinical utility
In our study, LA-GS alone provided higher diagnostic accu-
racy for resting or exercise-induced pathological LAP eleva-
tion in HF patients, as compared to the multi-parametric 
ASE/EACVI algorithm. Thus, routine LA-GS measure-
ments might provide a simple and robust tool in the setting 
of HF diagnostics and prognostication. Nevertheless, despite 
LA-GS constituting the best single non-invasive metric, its 
correlation with invasively measured pressures was still only 
moderate. Especially in case of reduced LA-GS, there was a 
considerable overlap between patients with normal and ele-
vated LAP values. This ultimately advocates for the prefer-
ential use of various metrics instead of single measurements 
in the setting of LAP estimation. In addition, future studies 
are warranted for evaluating the possible incremental val-
ues of LA-GS measurements in context of novel HF device 
therapies, such as the inter-atrial shunt device implantation 
[28–30].
Limitations
This is a single center study performed on a limited number 
of patients, still to the best of our knowledge it is the largest 
of its kind with echocardiographic and parallel resting and 
stress invasive measurements reported. Referral for RHC 
constitutes an important selection bias;, therefore, whether 
LA-GS is a better discriminator of elevated LAP compared 
to other non-invasive indices in a non-selected population 
cannot be assessed. The present study did not include a 
validation cohort, which warrants further studies to validate 
the established cut-off values as a necessary next step. AF is 
common in HF. Similarly, to other echocardiographic indi-
ces, according to our results LA-GS does not reliably reflect 
LAP in AF, which hinders the routine applicability of this 
metric. In contrast, LA-GS remained a reliable marker in 
patients on VP; however, the sample size of only 32 patients 
in this subgroup warrants confirmation in larger studies. 
Importantly, LA-GS measurements are not directly compa-
rable to results obtained by deformation analysis packages 
from different vendors, thus the current results might not 
be representative in studies performed with different instru-
mentation. Finally, our cohort included a large number of 
highly symptomatic patients with extensive LA remodeling, 
warranting validation of this approach in less severe cases.
Conclusion
We demonstrate that LA-GS comprises a feasible and fairly 
accurate tool for the identification of abnormally elevated 
LAP either at rest or on exertion in patients with known or 
suspected heart failure. This together with the revealed prog-
nostic value in HF patients advocates for the incremental 
value of LA-GS in non-invasive HF diagnostics.
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